Filter News
Area of Research
- (-) Functional Materials for Energy (2)
- (-) National Security (34)
- (-) Neutron Science (25)
- (-) Nuclear Science and Technology (11)
- Advanced Manufacturing (6)
- Biological Systems (2)
- Biology and Environment (79)
- Building Technologies (2)
- Clean Energy (167)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (3)
- Computer Science (16)
- Electricity and Smart Grid (3)
- Energy Sciences (2)
- Fusion and Fission (10)
- Fusion Energy (3)
- Isotopes (26)
- Materials (86)
- Materials for Computing (17)
- Mathematics (1)
- Quantum information Science (7)
- Sensors and Controls (1)
- Supercomputing (128)
News Topics
- (-) Bioenergy (10)
- (-) Computer Science (33)
- (-) Energy Storage (10)
- (-) Frontier (3)
- (-) Grid (7)
- (-) Isotopes (5)
- (-) Machine Learning (16)
- (-) Polymers (1)
- (-) Sustainable Energy (6)
- (-) Transformational Challenge Reactor (3)
- 3-D Printing/Advanced Manufacturing (12)
- Advanced Reactors (12)
- Artificial Intelligence (19)
- Big Data (8)
- Biology (9)
- Biomedical (15)
- Biotechnology (2)
- Buildings (2)
- Chemical Sciences (4)
- Clean Water (2)
- Climate Change (5)
- Composites (1)
- Coronavirus (11)
- Cybersecurity (19)
- Decarbonization (6)
- Environment (14)
- Exascale Computing (1)
- Fossil Energy (1)
- Fusion (10)
- High-Performance Computing (7)
- Materials (18)
- Materials Science (28)
- Mathematics (1)
- Microscopy (3)
- Molten Salt (4)
- Nanotechnology (11)
- National Security (34)
- Neutron Science (101)
- Nuclear Energy (41)
- Partnerships (4)
- Physics (11)
- Quantum Computing (1)
- Quantum Science (8)
- Security (12)
- Simulation (2)
- Space Exploration (8)
- Summit (7)
- Transportation (7)
Media Contacts
Two of the researchers who share the Nobel Prize in Chemistry announced Wednesday—John B. Goodenough of the University of Texas at Austin and M. Stanley Whittingham of Binghamton University in New York—have research ties to ORNL.
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
Ionic conduction involves the movement of ions from one location to another inside a material. The ions travel through point defects, which are irregularities in the otherwise consistent arrangement of atoms known as the crystal lattice. This sometimes sluggish process can limit the performance and efficiency of fuel cells, batteries, and other energy storage technologies.
Scientists at the Department of Energy’s Oak Ridge National Laboratory are working to understand both the complex nature of uranium and the various oxide forms it can take during processing steps that might occur throughout the nuclear fuel cycle.
Gleaning valuable data from social platforms such as Twitter—particularly to map out critical location information during emergencies— has become more effective and efficient thanks to Oak Ridge National Laboratory.
A University of South Carolina research team is investigating the oxygen reduction performance of energy conversion materials called perovskites by using neutron diffraction at Oak Ridge National Laboratory’s Spallation Neutron Source.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have created a recipe for a renewable 3D printing feedstock that could spur a profitable new use for an intractable biorefinery byproduct: lignin.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.